- DocumentAMSTAR 2 Critical appraisal tooluploaded byaslamali_hashmi
- DocumentOverlap time is an independent risk factor of radiation pneumonitis for patients treated with simultaneous EGFR‑TKI and thoracic radiotherapyuploaded byaslamali_hashmi
- DocumentEffect of thoracic radiotherapy dose on the prognosis of advanced lung adenocarcinoma harboring EGFR mutationsuploaded byaslamali_hashmi
- DocumentJanus Kinase Inhibitors and Risk of Venous Thromboembolismuploaded byaslamali_hashmi
- DocumentLocal Therapy Combined With First-Line EGFR Tyrosine Kinase Inhibitor Achieves Favorable Survival in Patients With EGFR-Mutant Metastatic Non-Small Cell Lung Canceruploaded byaslamali_hashmi
- DocumentSerious Infection Rates Among Patients with Select Autoimmune Conditionsuploaded byaslamali_hashmi
- DocumentRole of Anti Oxidantuploaded byaslamali_hashmi